| 1 |
33982799 | NOXA-mediated degradation of MCL1 and BCL2L1 causes apoptosis of daunorubicin-treated human acute myeloid leukemia cells. | 2021 Nov |
4 |
| 2 |
31222822 | MicroRNA-33b regulates sensitivity to daunorubicin in acute myelocytic leukemia by regulating eukaryotic translation initiation factor 5A-2. | 2020 Jan |
1 |
| 3 |
30470795 | Impact of elevated anti-apoptotic MCL-1 and BCL-2 on the development and treatment of MLL-AF9 AML in mice. | 2019 Jul |
1 |
| 4 |
30622244 | Erythropoietin inhibits chemotherapy-induced cell death and promotes a senescence-like state in leukemia cells. | 2019 Jan 8 |
1 |
| 5 |
30745844 | miR-9 Enhances the Chemosensitivity of AML Cells to Daunorubicin by Targeting the EIF5A2/MCL-1 Axis. | 2019 |
1 |
| 6 |
30361682 | Repression of Mcl-1 expression by the CDC7/CDK9 inhibitor PHA-767491 overcomes bone marrow stroma-mediated drug resistance in AML. | 2018 Oct 25 |
1 |
| 7 |
27103402 | Binding of Released Bim to Mcl-1 is a Mechanism of Intrinsic Resistance to ABT-199 which can be Overcome by Combination with Daunorubicin or Cytarabine in AML Cells. | 2016 Sep 1 |
3 |
| 8 |
22554523 | Downregulation of Mcl-1 by daunorubicin pretreatment reverses resistance of breast cancer cells to TNF-related apoptosis-inducing ligand. | 2012 May 25 |
2 |
| 9 |
22829255 | Targeting MCL-1 sensitizes FLT3-ITD-positive leukemias to cytotoxic therapies. | 2012 Mar |
1 |
| 10 |
17498302 | Pre-apoptotic response to therapeutic DNA damage involves protein modulation of Mcl-1, Hdm2 and Flt3 in acute myeloid leukemia cells. | 2007 May 11 |
2 |